There are 2789 resources available
446P - Bayesian monitoring of lapatinib (L) plus trastuzumab (T) treatment of HER2 positive metastatic colorectal cancer (mCRC): An observational cohort study
Presenter: Alessio Amatu
Session: ePoster Display
371P - Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain
Presenter: Jens Tijtgat
Session: ePoster Display
284P - Trastuzumab emtansine (T-DM1) in Asian patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC): Data from the phase III EMILIA study
Presenter: Seock-Ah Im
Session: ePoster Display
373P - Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study
Presenter: Olav Yri
Session: ePoster Display
374P - A real-world application of aqueous humor and vitreous fluid for the diagnosis of vitreoretinal lymphoma and treatment monitoring
Presenter: Xiaoxiao Wang
Session: ePoster Display
306P - Real-world study of treatments received and treatment satisfaction among HER2- advanced breast cancer (ABC) patients in EU3 and US
Presenter: Katie Lewis
Session: ePoster Display
307P - Overall survival in metastatic breast cancer patients according to different follow up strategies for early breast cancer
Presenter: Eva Blondeaux
Session: ePoster Display
377P - Comparison of current guidelines and real-world evidence data for the treatment of glioblastoma across Europe
Presenter: Carrmen Escorial
Session: ePoster Display
379TiP - TEM-GBM: A phase I-IIa clinical study of genetically modified Tie-2-expressing monocytes in patients with glioblastoma multiforme
Presenter: Gaetano Finocchiaro
Session: ePoster Display